tiprankstipranks
Trending News
More News >
Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179)
:2179
Hong Kong Market

Compare Jiangsu Recbio Technology Co., Ltd. Class H (2179) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.40B
-3.40
-39.57%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
CStone Pharmaceuticals
HK$5.34
HK$7.80B
-17.23
129.49%
SinoMab Bioscience Ltd.
HK$1.39
HK$1.87B
-9.46
34.65%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.01
-3.34
-40.00%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2616
CStone Pharmaceuticals
5.37
3.14
140.81%
HK:3681
SinoMab Bioscience Ltd.
1.36
0.35
34.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts